Published in Res Virol on March 07, 1991
Antigenic and molecular characterization of bat rabies virus in Europe. J Clin Microbiol (1992) 1.70
Screening of active lyssavirus infection in wild bat populations by viral RNA detection on oropharyngeal swabs. J Clin Microbiol (2001) 1.53
Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus. Proc Natl Acad Sci U S A (1983) 4.54
Genetic polymorphism in the rabies virus nucleoprotein gene. Virology (1995) 3.43
PCR technique as an alternative method for diagnosis and molecular epidemiology of rabies virus. Mol Cell Probes (1991) 1.87
Evolution of European bat lyssaviruses. J Gen Virol (1997) 1.86
Antigenic and molecular characterization of bat rabies virus in Europe. J Clin Microbiol (1992) 1.70
The neural cell adhesion molecule is a receptor for rabies virus. J Virol (1998) 1.60
Intravitam diagnosis of human rabies by PCR using saliva and cerebrospinal fluid. J Clin Microbiol (1998) 1.59
Clinically silent rabies infection in (zoo) bats. Vet Rec (1998) 1.58
Antigenic sites on the CVS rabies virus glycoprotein: analysis with monoclonal antibodies. J Gen Virol (1983) 1.50
Rabies virus infects mouse and human lymphocytes and induces apoptosis. J Virol (1997) 1.49
Localization and immunological characterization of antigenic domains of the rabies virus internal N and NS proteins. Virus Res (1987) 1.42
Fighting rabies in Africa: the Africa Rabies Expert Bureau (AfroREB). Vaccine (2008) 1.41
Molecular epidemiology of rabies virus in France: comparison with vaccine strains. J Gen Virol (1992) 1.30
Antigenic diversity of the glycoprotein and nucleocapsid proteins of rabies and rabies-related viruses: implications for epidemiology and control of rabies. Rev Infect Dis (1989) 1.27
Multiple sclerosis retrovirus particles and recombinant envelope trigger an abnormal immune response in vitro, by inducing polyclonal Vbeta16 T-lymphocyte activation. Virology (2001) 1.22
Antigenic variants of CVS rabies virus with altered glycosylation sites. Virology (1985) 1.20
The evolutionary dynamics of canid and mongoose rabies virus in Southern Africa. Arch Virol (2007) 1.17
Mechanisms of rabies virus neutralization by glycoprotein-specific monoclonal antibodies. Virology (1987) 1.16
Dynamics of rabies virus quasispecies during serial passages in heterologous hosts. J Gen Virol (1999) 1.14
Investigation of the antigenic structure of rabies virus glycoprotein by monoclonal antibodies. Dev Biol Stand (1984) 1.08
Characterisation of a recently isolated lyssavirus in frugivorous zoo bats. Arch Virol (2000) 1.06
Persistent infection of B lymphocytes by bovine respiratory syncytial virus. Virology (2001) 1.06
Abortive rabies virus central nervous infection is controlled by T lymphocyte local recruitment and induction of apoptosis. J Neurovirol (2000) 1.01
Presence of European bat lyssavirus RNas in apparently healthy Rousettus aegyptiacus bats. Arch Virol (2002) 1.00
Sexist diseases. Perspect Biol Med (1998) 1.00
An imported case of canine rabies in Aquitaine: investigation and management of the contacts at risk, August 2004-March 2005. Euro Surveill (2005) 0.98
Immunity against the European bat rabies (Duvenhage) virus induced by rabies vaccines: an experimental study in mice. Vaccine (1988) 0.97
Molecular variation in the nucleoprotein gene (ORF7) of the porcine reproductive and respiratory syndrome virus (PRRSV). Virus Res (1998) 0.95
Antigenic sites on the ERA rabies virus nucleoprotein and non-structural protein. J Gen Virol (1985) 0.93
A modified rapid enzyme immunoassay for the detection of rabies and rabies-related viruses: RREID-lyssa. Biologicals (1992) 0.92
Absence of the p55 Kd TNF-alpha receptor promotes survival in rabies virus acute encephalitis. J Neurovirol (2000) 0.90
Genomics and structure/function studies of Rhabdoviridae proteins involved in replication and transcription. Antiviral Res (2010) 0.90
Evolution of bovine respiratory syncytial virus. J Virol (2000) 0.90
Human rabies vaccines induce neutralising antibodies against the European bat rabies virus (Duvenhage) Lancet (1986) 0.88
Protective activity of a murine monoclonal antibody against European bat lyssavirus 1 (EBL1) infection in mice. Vaccine (1993) 0.88
Use of a monoclonal antibody for quantitation of rabies vaccine glycoprotein by enzyme immunoassay. J Biol Stand (1985) 0.88
Neuronal localization of copper-zinc superoxide dismutase protein and mRNA within the human hippocampus from control and Alzheimer's disease brains. Free Radic Res Commun (1991) 0.87
Conservation of a unique mechanism of immune evasion across the Lyssavirus genus. J Virol (2012) 0.87
Complete cloning and molecular organization of a rabies-related virus, Mokola virus. J Gen Virol (1989) 0.86
Production of monoclonal antibodies against the Pasteur (P.V.) strain of rabies virus: problems and results. Dev Biol Stand (1984) 0.86
Structure and expression in baculovirus of the Mokola virus glycoprotein: an efficient recombinant vaccine. Virology (1993) 0.86
Rabies encephalitis in a patient with AIDS: a clinicopathological study. Acta Neuropathol (1996) 0.86
Neuronal-specific expression of human copper-zinc superoxide dismutase gene in transgenic mice: animal model of gene dosage effects in Down's syndrome. Brain Res (1991) 0.85
High CRMP2 expression in peripheral T lymphocytes is associated with recruitment to the brain during virus-induced neuroinflammation. J Neuroimmunol (2007) 0.85
Molecular epidemiology of lyssaviruses: focus on the glycoprotein and pseudogenes. Onderstepoort J Vet Res (1993) 0.84
Rabies superantigen as a Vbeta T-dependent adjuvant. J Exp Med (1996) 0.83
Interaction of rabies vaccine with human rabies immunoglobulin and reliability of a 2-1-1 schedule application for postexposure treatment. Vaccine (1988) 0.83
Viral superantigen-induced hyporesponsiveness of T cells and polyclonal B cell activation in HIV-1 infection. Eur J Immunol (1994) 0.83
[Human rabies in France in 2004: update and management]. Med Mal Infect (2004) 0.82
Phylogenetic analysis of rabies viruses from Burkina Faso, 2007. Zoonoses Public Health (2010) 0.82
Fatal case of imported human rabies in Amadora, Portugal, August 2011. Euro Surveill (2012) 0.82
Nucleocapsid specific T and B cell responses in humans after rabies vaccination. Virus Res (1992) 0.81
Measurement of rabies virus N protein in rabies vaccines. Res Virol (1995) 0.81
Activation of human tonsil lymphocytes by rabies virus nucleocapsid superantigen. Clin Immunol Immunopathol (1995) 0.81
Rabies virus ocular disease: T-cell-dependent protection is under the control of signaling by the p55 tumor necrosis factor alpha receptor, p55TNFR. J Virol (2001) 0.81
Selective role for the p55 Kd TNF-alpha receptor in immune unresponsiveness induced by an acute viral encephalitis. J Neuroimmunol (2001) 0.80
Combined use of radioimagers and radioactive 3'OH DNA nick end labelling to quantify apoptosis in cell lines and tissue sections: applications to virus-induced apoptosis. Apoptosis (1999) 0.79
Characterization of rabies virus strains used for vaccine production by means of monoclonal antibodies. Dev Biol Stand (1984) 0.79
Superoxide dismutase and Parkinson's disease. Lancet (1990) 0.79
The VIZIER project: preparedness against pathogenic RNA viruses. Antiviral Res (2007) 0.79
Active monitoring of EBLV infection in natural colonies of the mouse-eared Bat (Myotis myotis). Dev Biol (Basel) (2008) 0.79
[4 cases of recurring jaundice in pregnancy]. Bull Fed Soc Gynecol Obstet Lang Fr (1971) 0.78
[The fight against rabies in Africa: from recognition to action]. Bull Soc Pathol Exot (2010) 0.78
Immunopotentiation of the antibody response against influenza HA with apoptotic bodies generated by rabies virus G-ERA protein-driven apoptosis. Vaccine (2005) 0.78
[Specificity of monoclonal antibodies obtained with the Paster PV rabies virus strain]. Rev Elev Med Vet Pays Trop (1984) 0.78
Human rabies despite postexposure vaccination. Eur J Clin Microbiol Infect Dis (1999) 0.78
WELYSSA: a simple tool using mouse monoclonal antibodies for the detection of lyssavirus nucleocapsid in rabies suspected specimens. Dev Biol (Basel) (2008) 0.78
[Don't forget rabies!]. Med Mal Infect (2005) 0.78
Monoclonal antibody studies of rabies viruses isolated from Thailand. Southeast Asian J Trop Med Public Health (1990) 0.78
[Rabies encephalomyelitis with myocarditis and pancreatitis. Report on a case recently imported into France]. Ann Pathol (1992) 0.78
Genomic characterization of Sebokele virus 1 (SEBV1) reveals a new candidate species among the genus Parechovirus. J Gen Virol (2013) 0.77
Evaluation of a nested reverse transcription-PCR assay based on the nucleoprotein gene for diagnosis of spontaneous and experimental bovine respiratory syncytial virus infections. J Clin Microbiol (1999) 0.77
[Comparative anatomical result of conservative treatment and surgery in severe recent sprains of the ankle (author's transl)]. J Chir (Paris) (1977) 0.77
Rabies-specific production of interleukin-2 by peripheral blood lymphocytes from human rabies vaccinees. Vaccine (1991) 0.77
Retro-orbital route for brain specimen collection for rabies diagnosis. Vet Rec (1991) 0.75
T and B cell human responses to European bat lyssavirus after post-exposure rabies vaccination. Clin Exp Immunol (1991) 0.75
Comparative study of two human diploid rabies vaccines administered with antirabies globulin. Vaccine (1988) 0.75
[Transfixion by a bullet of the innominate vein, trachea and esophagus. Therapeutic considerations]. Chirurgie (1976) 0.75
[Genetic diversity of Lyssavirus]. Bull Soc Pathol Exot (2000) 0.75
[Application of McAbs against rabies nucleocapsid in diagnosis of rabies street virus]. Zhonghua Liu Xing Bing Xue Za Zhi (2005) 0.75
Rabid dog illegally imported to France from Morocco, August 2011. Euro Surveill (2011) 0.75
[Epidemiologic monitoring of human rabies in an endemic canine rabies area in the Ivory Coast]. Med Mal Infect (2010) 0.75
[Suicidal behavior and serum creatine kinase activity]. Ann Med Psychol (Paris) (1980) 0.75
Information processing in large-scale cerebral networks: the causal connectivity approach. Biol Cybern (2000) 0.75
Rabies vaccines from Pasteur's time up to experimental subunit vaccines today. Adv Biotechnol Processes (1990) 0.75
[Application of an immunoenzyme method to the titration of neutralized rabies antibodies in cell culture]. J Biol Stand (1985) 0.75
Rabies in vaccinated dogs in Gabon. Vet Rec (1988) 0.75